Clinical trial
A Multifactorial 'Urica Cor Intervention' to Prevent Cardiovascular Disease in People With Gout: Protocol for the Multicentre, Randomised Controlled, Blinded Endpoint URICORI Trial
NCT04459936 is registered in ClinicalTrials.gov with Torkell Ellingsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multifactorial 'Urica Cor Intervention' to Prevent Cardiovascular Disease in People With Gout: Protocol for the Multicentre, Randomised Controlled, Blinded Endpoint URICORI Trial
- Lead sponsor
- Torkell Ellingsen
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- November 24, 2020
- Completion date
- February 1, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
behavior, smoking, cardiovascular diseases, diabetes, dyslipidemias, gout, hypertension